Back to search

Spain· ES:83179

IMIDAPRIL DARI PHARMA 20 MG COMPRIMIDOS EFG

A imidapril product containing imidapril, registered in Spain by Dari Pharma S.L.. The same ATC class is registered in 6 of our 19 countries.

ATC C09AA16

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedIMIDAPRIL DARI PHARMA 20 MG COMPRIMID…ATCC09AA16REGISTER NO.ES:83179PACKS LISTED1CHECKEDAugust 12, 2026

Where it is registered

Imidapril is registered in 6 of 19 countries.

Countries holding a registration under ATC C09AA16 (imidapril), each read from that country’s own register.

  • This record: Spain, from AEMPS CIMA (Spain)
  • 4 of them publish a price we can compare per daily dose

Imidapril · ATC C09AA16

6 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Japan
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of imidapril costs, country by country.

Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.

  • Spain: $0.24 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Imidapril · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • ES Spain$0.24
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AEMPS CIMA (Spain)
Active substance
imidapril
Manufacturer
Dari Pharma S.L.
Country
Spain (ES)
ATC code
C09AA16
ATC class
Imidapril
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
August 12, 2026

Packs & prices · 1

1 priced
  • cima_codigo
    721991
    28
    EUR 11.74

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

21 interactions on record for imidapril.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Imidapril · interactions on record

21 records

21 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Imidapril in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All imidapril products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Austria · Tanatril
  • Czechia · Tanatril
  • United Kingdom (Northern Ireland) · Imidapril Northumbria Pharma, Imidapril Northumbria Pharma Ltd
  • Poland · Tanatril
  • Portugal · Cardipril

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b91efc42-87e5-4e11-9b16-a043b38004cd
GET /v1/drugs/b91efc42-87e5-4e11-9b16-a043b38004cd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":1528149600000}",
  "nregistro": "83179",
  "substance": "imidapril"
}

See everything about imidapril.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.